Search

everythinglearnresearchcommunity

for

Search:↓

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Early detection and multidisciplinary treatment are crucial for managing Papillon-Lefévre syndrome.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Infant skin cells may be less capable of repairing UV-induced DNA damage than adult cells.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Nanotechnology shows promise for better drug delivery and cancer treatment.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

CTUMP's Herb shampoo promotes faster and denser hair growth.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Antibody treatments show promise for hair loss but need more research.

Sassle's haircare business is financially viable and profitable.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Latanoprost is more effective than minoxidil for treating alopecia areata.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

The Scalp Coverage Scoring method reliably measures hair density from images.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Sunekos® effectively improves labia majora appearance and is well-tolerated.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.